Update of China-ADNI Kuncheng Li, MD. PhD.

Slides:



Advertisements
Similar presentations
Emmanuel A Stamatakis Centre for Speech, Language and the Brain, Department of Experimental Psychology, University of Cambridge School of Psychological.
Advertisements

ERP Characteristics of Early AD
K OREAN ADNI … WHERE ARE WE NOW Seol-Heui Han, MD, PhD. On behalf of Preparatory Committee for K-ADNI Seol-Heui Han, MD, PhD. On behalf of Preparatory.
Department of Neurology, Mayo Clinic Arizona
December, NEED FOR VALIDATED BIOMARKERS FOR AD TRIALS Biomarkers useful in Phase 2 to make decisions about Phase 3 (e.g. doses) Biomarkers useful.
Disclosures/Conflicts Consulting: GE Healthcare Bayer Abbott Elan/Janssen Synarc Genentech Merck.
Alzheimer’s Disease Neuroimaging Initiative STEERING COMMITTEE April
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
"THE POTENTIAL OF MULTIMODAL MRI FOR UNDERSTANDING SPORTS CONCUSSION" Victoria Morgan, Ph.D., Manus Donahue, Ph.D., Megan Strother, M.D., Allen Sills,
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Dept. of Radiology, Xuanwu Hospital, Capital Medical University Beijing: Emeil: 首都 Update of China-ADNI Kuncheng Li.
How To Improve Memory Performance and Keep Your Brain Young Gary W. Small, MD Parlow-Solomon Professor on Aging Professor of Psychiatry & Biobehavioral.
©2012 MFMER | ADNI Clinical Core Paul Aisen Ron Petersen Michael Donohue Jennifer Salazar.
Update Arg-ADNI Gustavo E. Sevlever, Ricardo F. Allegri (*), Silvia Vázquez, Deborah R. Gustafson, Salvador M. Guinjoan, and Arg-ADNI group. Memory and.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Hypothesis of Neural Information Flow about Acupuncture — the new methods of meridian research General Hospital of PLA : Dr. Tong Li Dr. Ling Yin.
ASNR 2015 Poster# EP-19 Effect of Chemotherapy on Brain Structure and Cognition in Older Women with Breast Cancer: a Brain MRI Study 1 Bihong T. Chen MD.
Laurence Lacoste Ph. D, Paris, France 1*. Introduction : Why ?  Population’s Ageing is a Public Health issue and dementia for the Elderly a reality 
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
Alzheimer’s Disease Neuroimaging Initiative STEERING COMMITTEE Michael W. Weiner.
conflicts of interest to report.
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
PharmaCog WP5 / E-ADNI. Enrollment and follow-ups Clinical sites Maximum Minimum PATIENTS EXPECTED.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Apolipoprotein E and Gray Matter Loss in Mild Cognitive Impairment and Alzheimer’s Disease Spampinato MV, Goldsberry G, Mintzer J, Rumboldt Z Medical University.
Advanced brain imaging and neurodegenerative disorders. Dott.ssa Ingrid Inches.
CASES SERIES BRAIN FDG PET SCAN IN DEMENTIA PATIENTS
Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of Short- term conversion to AD: Results from ADNI Xuejiao.
INFLUENCE OF FRACTIONAL ANISOTROPY THRESHOLD FOR TRACT BASED DIFFUSION TENSOR ANALYSIS OF UNCINATE FASCICLES IN ALZHEIMER DISEASE Toshiaki Taoka, Toshiaki.
DECIDE: "Scientific and Clinical Perspectives“: Claudio Babiloni (UNIFG) and Giovanni Frisoni (IRCCS Brescia)
Update of China-ADNI Kuncheng Li, MD. PhD.
ADNI3 Clinical core Paul Aisen Ron Petersen Mike Donohue
Aka STEEL VALLEY SENIORS SURVEY (SVSS)
INDIA - ADNI Dr Naren Rao
31 Speaker: Hanna Lu (PhD Candidate of Medical Sciences, CUHK)
Copyright © 2013 American Medical Association. All rights reserved.
Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI 3)
Rosa Maria Moresco University of Milan Bicocca
Manuela Tondelli, Gordon K. Wilcock, Paolo Nichelli, Celeste A
Arg-ADNI Patients’ Flowchart Patients Invited to ADNI Nº= 73
Update of China-ADNI Kuncheng Li, MD. PhD.
Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI 3)
Presenter: Dr. Patricio Chrem
Assoc. Prof. Martin Valis, M.D., Ph.D.
Use of Amyloid PET Scan in Early Diagnosis of Alzheimer’s Disease in a Secondary Care Memory Clinic Niki Schoonenboom, MD PhD1, Mohammed Akarriou, MD2;
Preventive Effect of Rifampicin on Alzheimer Disease Needs at Least 450 mg Daily for 1 Year: An FDG-PET Follow-Up Study - DOI: / Fig. 1.
DIFFUSION ABNORMALITY OF CORPUS CALLOSUM IN ALZHEIMER’S DISEASE
Imaging AD Progression Amyloid Imaging Agents.
PPMI in the Medical Literature
ADI Disease International 7-10 March, 2012
INDIA - ADNI Dr Naren Rao
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
ADNI3 Clinical core Paul Aisen Ron Petersen Mike Donohue
ADNI Clinical Core Paul Aisen Ron Petersen Michael Donohue
Ron Petersen & Paul Aisen
Volume 63, Issue 2, Pages (July 2009)
Presenter: Dr. Patricio Chrem
Update of China-ADNI Kuncheng Li, MD. PhD.
Michael Ewers, Reisa A. Sperling, William E. Klunk, Michael W
Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI 3)
Network hubs in the human brain
Boston Naming Test predicts deterioration of cerebrospinal fluid biomarkers in pre-symptomatic Alzheimer’s disease Charleen Wilder, MA, Kristina Moncrieffe,
Biomarker Modeling of Alzheimer’s Disease
Tharick A. Pascoal, Sulantha Mathotaarachchi, Monica Shin, Andrea L
Progress Seminar 권순빈.
Clinical Concepts Emerging from fMRI Functional Connectomics
Volume 63, Issue 2, Pages (July 2009)
Fig. 2. Default mode network (DMN) patterns in each of the 3 groups and longitudinal changes after treatment. (A–C) ... Fig. 2. Default mode network (DMN)
Presentation transcript:

Update of China-ADNI Kuncheng Li, MD. PhD. Dept. of Radiology, Xuanwu Hospital, Capital Medical University Beijing:100053, Email: cjr.likuncheng@vip.163.com Dear Chair, colleagues, goodmorning! I am Kuncheng Li, from Beijing. on behalf of China-ADNI to report our progress. WW-ADNI 2018, Chicago, U.S.

Outline General information of China-ADNI Progress of the China-ADNI The report have two parts. Part one is to introduce general information of China-ADNI.

Scientist advisory board China-ADNI Scientist advisory board Administration committee PI: Prof. Kuncheng Li, CMU CO-PI: Prof. Jun Wang, BJU CO-PI: Prof. Hongzheng Wang, BUMC Clinical core Liyan Qiao MRI core Kuncheng Li PET core Fang Li Biomarker and Genetics Core Jun Wang/Yan Zhang Biostatistics and Informatics core Li Wang DATA Post process Core Yong Fang Patholoy core Cuidi Wang Although officially joined WW-ADNI only 7 years of history, but we have made the gradual progress. China-ADNI have a scientist advisory board, clinical, MRI, PET, pathology, biomarker and genetics, biostatistics and informatics, and data post process core. PI is me, kuncheng Li, and Jun Wang, Hongzhen Wang are co-PI. After more than four years running, the workflow among different core became more smoothly.

Initial plan of China-ADNI 800-1000 subjects (80 sites) Normal Early MCI Late MCI Mild AD 200-250 The initial plan of China-ADNI is to collect 800-1000 subject that includes volunteer as normal control, early and late MCI, mild AD four groups.

Research plan Neuropsychological battery Biomarkers: Blood: ApoE gene polymorphism, Amyloid 40, 42, and tau CSF: Amyloid 40,42 and tau MRI: Multimodal PET: 18F-FDG 18F-AV-45 This is research plan: We have to collect the data of neuropsychological battery, APOE gene polymorphism, Amyloid 40,42 and tau in blood and amyloid 40,42, and tau in CSF. Imaging examination including multimodal MRI,18F-FDG PET, and AV45 amyloid imaging.

Outline General information of China-ADNI Progress of the China-ADNI The second parts of the report is the progress of the China-ADNI over the past year.

62 new subjects enrolled in the past 1 year Enrolled Subjects 62 new subjects enrolled in the past 1 year Normal MCI AD 12 21 29 we have collected 62 new subject in the past 12 months, so total of 146 cases in China-ADNI.

Neuropsychological battery Screening: MMSE, LM-I, LM-II, GDS, CDR,Hachinski Baseline: ADAS-Cog,CWRT,MoCA, BNT, Rey AVLT(30’ Delay), Category fluency, Trial making test A&B,NPI, FAQ 6 month: MMSE, CDR, MoCA, ADAS-Cog,E-cog,BNT, Rey AVLT(30’ Delay), Category fluency, Trial making test A&B, NPI, FAQ 12 month,24 month 36 month: MMSE, LM-I, LM-II,DR,ADAS- Cog, E-cog, Rey AVLT(30’ Delay), MoCA,Category fluency Trial making test A&B,BNT, NPI , FAQ Neuropsychological tests completely follow WW-ADNI‘s plan. Including screening, baseline, and follow-up test.

MMSE examination follow-up The average MMSE score of normal volunteers after 2 years follow-up was almost of full score. The average MMSE score of MCI slight increase after one year, then decrease at two years later. The changing trend of AD is the same as that of MCI

MoCA examination follow-up The average MoCA score are no significantly change in NC, and MCI during the two years follow-up, however, decreased. in AD. AD group only have a years follow-up.

MRI Study Standard protocol for MRI scanning Quality control among different sites Improve the post-processing methods We have performed standard protocol for MRI scanning according to the WW-ADNI guideline, and implement quality control among different sites, and improve the post-processing methods.

Scanning protocol of MRI 3D T1 volume Diffusion tensor imaging Resting state fMRI Arterial spin labelling Susceptibility weighted imaging Scanning protocol of MRI is including 3D-T1 volume, DTI, rs-fMRI, ASL perfusion and SWI of brain.

Local-to-remote cortical connectivity in aMCI a novel rs-fMRI connectome index, regional functional homogeneity on the 2-dimensional cortical surface, to detect full-cortex vertex-wise changes of the local rs-fMRI connectivity seed based functional connectivity to explore the remote rs-fMRI connectivity We perform cortical connectivity analysis, including local and remote rs-fMRI connectivity. Zhang et al. Neurobiology of Aging,2017,56:138-149

Local-to-remote cortical connectivity in aMCI Significantly lower local connectivity in default mode network and higher local connectivity in the somatomotor network observed in aMCI. Abnormal remote connectivity was primarily detectable within the default mode network as decreased however, increased in the somatomotor and attention networks. Abnormalities in the remote default mode network connectivity were significantly associated with episodic memory performance in patients. We found that significantly lower local connectivity in default mode network and higher local connectivity in the somatomotor network observed in aMCI.Abnormal remote connectivity relevant to local connectivity was primarily detectable within the default mode network as decreased however, increased in the somatomotor and attention networks. Abnormalities in the remote default network connectivity were significantly associated with episodic memory performance in patients.

Reduced local synchronization in aMCI was located in the default mode network (right posterior cingulate cortex), and the increased local synchronization mainly occurred in the somatomotor network (left precentral sulcus, and postcentral sulcus). Reduced local synchronization in aMCI was located in the default mode network (right posterior cingulate cortex), and the increased local synchronization mainly occurred in the somatomotor network (left precentral sulcus and postcentral sulcus.

aMCI patients showed decreased remote seed-based functional connectivity between the right PCC and left PCC/precuneus and enhanced seed-based remote functional connectivity between right posterior cingulate cortex, the bilateral central sulcus and right precentral gyrus aMCI patients showed decreased remote seed-based functional connectivity between the right posterior cingulate cortex and left posterior cingulate cortex/precuneus and enhanced seed-based remote functional connectivity between right posterior cingulate cortex the bilateral central sulcus and right precentral gyrus.

3D-ASL evaluation of AD Decreased rCBF was observed in a series of cerebral cortex, including bilateral HP, PCC, fronto-temporal cortex, especially in the right PCC Abnormal perfusion in AD may be an significant biomarker in the early diagnosis The 3D-ASL was used for evaluation of AD, we found that decreased rCBF in a series of cerebral cortex, including bilateral HP, PCC,fronto-temporal cortex, especially in the right PCC. Abnormal perfusion in AD may be an significant biomarker in the early diagnosis.

Epidemiological Investigation in Underdeveloped Area (Liupanshui) 501(M 275, F 226), 51~82 years (61.4±7.2) illiteracy 286 (57.1%) primary school education 175 (34.9%) junior high school 40 (8.0%) senior high school and above 0 We have a epidemiological investigation in backward and poor areas in Liupanshui, 501 middle and old aged people were investigated, average age 61.4±7.2 years,among them illiteracy people was 57.1%,primary school education was 34.9%,junior high school was 8.0%,and no person educational level was higher than senior high school.

Incidence rate of cognition impairment in different gender gender No. Cognition impairment patients M 275 39(13.1%)﹡ F 226 79(35.0%) Total 501 118(23.6%) Incidence rate of cognition impairment in different age level age(year) No. Cognition impairment patients 50~ 222 49(22.1%)﹡ 60~ 214 51(23.8%)﹡ 70~ 54 13(24.1%)﹡ 80~ 11 5(45.5%) There were 23.6% people with cognition impairment and more women than men. The people under 80 years old suffered from cognitive impairment is 22.1%~24.0%, and those over 80 years old is up to 45.5%

<1 <3 <5 <10 >10 Incidence rate of cognition impairment in different degree of education Degree of education No. Cognition impairment patients illiteracy 286 94(32.9%) primary School 175 22(12.6%)﹡ junior high school 40 2(5.0%)﹡ Incidence rate of cognition impairment in different annual family income Annual family income (ten thousands yuan) No. Cognition impairment patients <1 59 29(49.12) <3 215 53(24.7%)﹡ <5 174 33(19.0%)﹡ <10 52 3(5.8%)﹡ >10 1 0(0%)﹡ The lower level of education, the higher the proportion with cognitive impairment, The lower annual household income, the higher the proportion with cognitive impairment suffered.

Traditional Chinese Medicine in AD Four-gate acupuncture could slow down the progress of perfusion deficit in AD and MCI by ASL perfusion MRI Traditional Chinese Tuina could improve the quality of life of AD patients We try to apply traditional Chinese medicine to treat AD also, and found that four-gate acupuncture could slow down the progress of perfusion deficit in AD by ASL perfusion MRI. Traditional Chinese Tuina could improve the quality of life of AD patients

Baseline of perfusion of AD and NC group Gender(M/F) age Education years MMSE MoCA AD 3/7 70.7±8.0 10.4±3.1 17.4±2.6 14.3±3.8 NC 2/8 64.5±4.9 9.8±3.3 29.0±1.1 26.1±1.4 t value 2.087 -0.493 0.422 -12.933 -9.171 P value 0.628 0.051 0.000* Please look at the location map of Siguan point: this is Hegu, that is Taichong. The table was results comparison between NC and AD group. Four-gate acupoint : hegu and taichong

Compared to NC, decreased rCBF was observed in AD in bilateral HP, PCC, and fronto-temporal cortex, especially in the right PCC. Whereas no significant difference was observed in the perfusion changes between AD and NC after the acupuncture on the four-gate acupoint for six months. Compared to NC, decreased rCBF was observed in AD in bilateral HP, PCC, and fronto-temporal cortex, especially in the right PCC. Whereas no significant difference was observed in the perfusion changes between AD and NC after the acupuncture on the four-gate acupoint for six months.

Treatment of AD by Traditional Chinese Tuina We try to treat the patients with AD by Traditional Chinese Tuina like this.

Treatment of AD by Traditional Chinese Tuina The purpose of the study is to improve the quality of life and reduce social and family burden. 83 AD patients were enrolled and divided into mild, moderate and severe groups. During Six months, each patient was treated no less than 5,300 times, and each process is managed, monitored and recorded during the treatment. The purpose is to improve the quality of life and reduce social and family burden. Total 83 AD patients were enrolled and divided into mild, moderate and severe groups.During six months,each patient was treated no less than 5,300 times, and each process is managed, monitored and recorded during the treatment.

Notes: 71 effective data according to statistics of MMSE score. Preliminary results Age group No. of patients MMSE Score increased MMSE Score decreased MMSE Score Un changed 50-60 5 100% 60-70 13 10 76.9% 3 23.1% 70-80 23 18 78.3% 13.0% 2 8.7% 80-90 25 20 80% 8% 15% 90-95 60% 1 20% total 71 56 78.9% 9 12.7% 6 8.5% Notes: 71 effective data according to statistics of MMSE score. This is preliminary results. Please look at the table, we can see the that MMSE score increases in most AD patients, The decrease of MMSE score only a few patients, only 6 patients MMSE score unchanged after Tuina treatment.

Preliminary results the mental state and the cognitive ability of time and location improved the flexibility of action increased the insomnia improved After treatment of AD by traditional Chinese Tuina, the mental state, and cognitive abilityof time and location of the AD patients was improved, the flexibility of action Increased, and the insomnia were improved also.

Acknowledgements all the colleague of China-ADNI the support from WW-ADNI Finally, I express my gratitude to all the colleague of China-ADNI, and many thanks to the support from WW-ADNI. So far we could catch pace up with WW-ADNI, and we can do more in future.